Source: BioSpace

Pharos: Pharos Capital Sells TechLab, Inc. to SSI Diagnostica

Pharos Capital Group, LLC ("Pharos"), a private equity firm based in Dallas and Nashville, announced today it has sold its stake in portfolio company TechLab, Inc. ("TechLab"), a leading developer and manufacturer of rapid, non-invasive diagnostic tests for infectious disease.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kneeland Youngblood's photo - Chairman & CEO of Pharos

Chairman & CEO

Kneeland Youngblood

CEO Approval Rating

89/100

Read more